与治疗牛皮的生物药物相关的抗脂自身抗体的患病率
Lixin Li1, Satoshi Toyama1, Yuka Mizuno1
1Department of Dermatology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Scientific reports
|July 10, 2024
概括
用于牛皮治疗的瘤缩因子 (TNF) 抑制剂与抗脂综合征 (APS) 自体的增加有关. 这些自身抗体与疾病严重程度和关节炎相关,但与临床APS症状无关.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 牛皮是一种慢性炎症状况,通常需要生物治疗.
- 已知TNF抑制剂具有自身抗体的产生,但在牛皮患者中与APS相关的自身抗体尚未得到研究.
- 生物药物如TNF,IL-17和IL-23抑制剂用于牛皮治疗.
研究的目的:
- 为了确定不同生物药物上的牛皮患者中APS相关自身抗体的患病率.
- 探索自身抗体产生与临床/血清学因素之间的联系.
- 为了研究牛皮病发病的免疫调节相互作用.
主要方法:
- 包括接受生物药物 (TNF,IL-17或IL-23抑制剂) 的牛皮患者.
- 收集了临床和血清学数据.
- 与患者数据一起分析了APS自身抗体.
主要成果:
- 与IL-17和IL-23抑制剂相比,TNF抑制剂显示出APS自身抗体的频率更高.
- 在TNF抑制剂使用者中,APS自身抗体与关节炎和在治疗开始时更高的疾病严重程度相关.
- 升高的牛皮区域和严重性指数 (PASI) 评分和ANA标位 (≥1:320) 预测了APS自身抗体的产生.
- 尽管自身抗体率增加,但没有观察到临床APS症状.
结论:
- 这项研究提供了全面的证据,证明在牛皮患者中使用TNF抑制剂时APS自身抗体增加.
- 这些发现表明,在牛皮病原发生过程中,它可能起到免疫调节作用,将自身免疫和炎症联系起来.
- 进一步的研究可能会澄清这些自身抗体在牛皮管理中的临床意义.
相关概念视频
01:29Autoimmune Disorders
409
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
409
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
128
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
128